TFC Financial Management’s Minerva Neurosciences NERV Stock Holding History

TFC Financial Management’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-186	Closed	-$414	–	1020
2024 Q4	$414	Hold	186	–	–	﹤0.01%	686
2024 Q3	$497	Hold	186	–	–	﹤0.01%	666
2024 Q2	$594	Hold	186	–	–	﹤0.01%	614
2024 Q1	$480	Hold	186	–	–	﹤0.01%	641
2023 Q4	$1.14K	Hold	186	–	–	﹤0.01%	503
2023 Q3	$1.28K	Hold	186	–	–	﹤0.01%	508
2023 Q2	$1.7K	Hold	186	–	–	﹤0.01%	461
2023 Q1	$298	Hold	186	–	–	﹤0.01%	598
2022 Q4	$296	Hold	186	–	–	﹤0.01%	522
2022 Q3	$2K	Hold	186	–	–	﹤0.01%	415
2022 Q2	$1K	Hold	186	–	–	﹤0.01%	485
2022 Q1	$1K	Hold	186	–	–	﹤0.01%	496
2021 Q4	$1K	Hold	186	–	–	﹤0.01%	544
2021 Q3	$3K	Hold	186	–	–	﹤0.01%	425
2021 Q2	$3K	Hold	186	–	–	﹤0.01%	414
2021 Q1	$4K	Hold	186	–	–	﹤0.01%	382
2020 Q4	$3K	Hold	186	–	–	﹤0.01%	400
2020 Q3	$5K	Buy	+186	New	+$5.03K	﹤0.01%	338

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFC Financial Management's NERV Position: Q1 2025 in Review

TFC Financial Management sold out of Minerva Neurosciences (NERV) in Q1 2025, closing a stake of 186 shares — an estimated $414 sold.

TFC Financial Management first reported a position in NERV in Q3 2020 and held it in 18 quarters. The position peaked at $5K in Q3 2020. 22 funds tracked by Wall St. Rank hold NERV as of Q1 2025.

TFC Financial Management reported no remaining Minerva Neurosciences position as of Q1 2025 after selling out during the quarter.
TFC Financial Management sold 186 Minerva Neurosciences shares in Q1 2025, an estimated $414.
TFC Financial Management first reported a position in Minerva Neurosciences in Q3 2020 and held it in 18 quarters.
TFC Financial Management's Minerva Neurosciences position peaked at $5K in Q3 2020.
22 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2025.

Based on TFC Financial Management's 13F filing for Q1 2025, filed 24 Apr 2025.